| 000 | 01251 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513052518.0 | ||
| 264 | 0 | _c19941222 | |
| 008 | 199412s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/BF00877922 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVaughan, D E | |
| 245 | 0 | 0 |
_aPost-myocardial infarction ventricular remodeling: animal and human studies. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cJun 1994 |
||
| 300 |
_a453-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xprevention & control |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aPfeffer, M A | |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 8 _gno. 3 _gp. 453-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00877922 _zAvailable from publisher's website |
| 999 |
_c7946692 _d7946692 |
||